The Promise and Challenge of Big Data for Pharma
Harvard Business
NOVEMBER 29, 2016
To be sure, anonymized insurance-claims data and electronic health record (EHR) data has been accessed and analyzed for many years. One of the biggest is how to make the transition from legacy technology and analytical competence to more-powerful and sophisticated analytical tools and analysis methodologies.
28 
Let's personalize your content